- Home
- CMPS vs HBB Comparison
CMPS vs HBB Comparison
Compare CMPS & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- HBB
- Stock Information
- Founded
- CMPS 2020
- HBB 1904
- Country
- CMPS United Kingdom
- HBB United States
- Employees
- CMPS N/A
- HBB N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- HBB Home Furnishings
- Sector
- CMPS Health Care
- HBB Consumer Discretionary
- Exchange
- CMPS Nasdaq
- HBB Nasdaq
- Market Cap
- CMPS 280.2M
- HBB 292.6M
- IPO Year
- CMPS 2020
- HBB 2017
- Fundamental
- Price
- CMPS $4.67
- HBB $18.93
- Analyst Decision
- CMPS Strong Buy
- HBB
- Analyst Count
- CMPS 7
- HBB 0
- Target Price
- CMPS $30.67
- HBB N/A
- AVG Volume (30 Days)
- CMPS 950.7K
- HBB 48.5K
- Earning Date
- CMPS 10-31-2024
- HBB 10-30-2024
- Dividend Yield
- CMPS N/A
- HBB 2.40%
- EPS Growth
- CMPS N/A
- HBB 107.04
- EPS
- CMPS N/A
- HBB 1.88
- Revenue
- CMPS N/A
- HBB $647,834,000.00
- Revenue This Year
- CMPS N/A
- HBB $4.60
- Revenue Next Year
- CMPS N/A
- HBB N/A
- P/E Ratio
- CMPS N/A
- HBB $10.08
- Revenue Growth
- CMPS N/A
- HBB 5.30
- 52 Week Low
- CMPS $4.00
- HBB $14.34
- 52 Week High
- CMPS $12.75
- HBB $31.78
- Technical
- Relative Strength Index (RSI)
- CMPS 46.00
- HBB 30.13
- Support Level
- CMPS $4.00
- HBB $18.54
- Resistance Level
- CMPS $4.66
- HBB $20.45
- Average True Range (ATR)
- CMPS 0.29
- HBB 0.93
- MACD
- CMPS 0.03
- HBB 0.29
- Stochastic Oscillator
- CMPS 57.76
- HBB 15.52
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels.